Anticancer agent 139
Compound 6h (Anticancer Agent 139) is a potent tubulin-binding small molecule, engaging Lys352 via π-cation interaction. It demonstrates high growth inhibition in SNB-19, OVCAR-8, and NCI-H460 cells, with broader moderate activity across multiple other cancer cell lines, supporting its use in anticancer mechanism and cytotoxicity studies.
Product Specifications
Field of Research
Signal Transduction
Molecular Formula
C16H12F3N3O
Molecular Weight
319.28
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-52023R-HRP-01 20 µL
BCL2A1 Recombinant Antibody, HRP Conjugated
Sign In for Pricing
View Details bsm-52023R-HRP-02 100 µL
BCL2A1 Recombinant Antibody, HRP Conjugated
Sign In for Pricing
View Details 
12-9083B-50 50 µg
Biotinylated Anti-Trop2 (sacituzumab biosimilar) mAb
Sign In for Pricing
View Details 
OR1084617-01 250 mg
2-methyl-1- (1-methyl-1H-indazol-5-yl) propan-1-one
Sign In for Pricing
View Details OR1084617-02 500 mg
2-methyl-1- (1-methyl-1H-indazol-5-yl) propan-1-one
Sign In for Pricing
View Details